takeda pharmaceutical co ltd
(4502:Tokyo Stock Exchange)
William W. Chin M.D.
Member of Takeda Global Advisory Board, Takeda Pharmaceutical Company Limited
|Age||Total Calculated Compensation||This person is connected to 34 board members in 3 different organizations across 4 different industries.|
See Board Relationships
Dr. William W. Chin, M.D serves as an Executive Dean of Research, Bertarelli Professor for Translational Medical Science and Professor of Medicine at Harvard Medical School (HMS). Dr. Chin served as Senior Vice President of Discovery & Clinical Research at Eli Lilly & Co. Dr. Chin served as the Vice President - Discovery Biology Research and Clinical Investigation of Eli Lilly & Co. since July 2003. Dr. Chin serves as a Member of Eli Lilly & Co.’s Senior Management Council. ...
1-1, Doshomachi 4-chomePhone: 81 6 6204 2111
Osaka, -- 540-8645
Fax: 81 6 6204 2880
Board Members Memberships*There is no Board Members Memberships data available.
Harvard Medical School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|Vincent A. Forlenza BD||Chairman, Chief Executive Officer and President|
Becton, Dickinson and Company
|Miles D. White||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|--||Compensation as of Fiscal Year 2013.|